Editorial: targeting aberrant hepatic inflammation for treatment of non-alcoholic steatohepatitis

被引：1
|
作者：
Muthiah, Mark D. [1 ,2 ]
Siddiqui, Mohammad S. [3 ]
机构：
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore
[2] Natl Univ Singapore Hosp, Dept Med, Div Gastroenterol & Hepatol, Singapore, Singapore
[3] Virginia Commonwealth Univ, Richmond, VA 23284 USA
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2022年 / 55卷 / 04期
关键词：
D O I：
10.1111/apt.16748
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：483 / 484
页数：2
相关论文
共 50 条
  • [31] Metformin in the treatment of patients with non-alcoholic steatohepatitis
    Uygun, A
    Kadayifci, A
    Isik, AT
    Ozgurtas, T
    Deveci, S
    Tuzun, A
    Yesilova, Z
    Gulsen, M
    Dagalp, K
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (05) : 537 - 544
  • [32] Pathophysiology of Non-Alcoholic Steatohepatitis and Basis for Treatment
    Pinzani, Massimo
    DIGESTIVE DISEASES, 2011, 29 (02) : 243 - 248
  • [33] Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment
    Zhu, Bo
    Chan, Siu-Lung
    Li, Jack
    Li, Kathryn
    Wu, Hao
    Cui, Kui
    Chen, Hong
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [34] Future trends in the treatment of non-alcoholic steatohepatitis
    Fiorucci, Stefano
    Biagioli, Michele
    Distrutti, Eleonora
    PHARMACOLOGICAL RESEARCH, 2018, 134 : 289 - 298
  • [35] Reply to "Statin treatment for non-alcoholic steatohepatitis"
    Dongiovanni, Paola
    Pihlajamaki, Jussi
    Romeo, Stefano
    Valenti, Luca
    JOURNAL OF HEPATOLOGY, 2016, 64 (01) : 242 - 243
  • [36] α-Tocopherol and antioxidants in the treatment of non-alcoholic steatohepatitis
    Dufour, JF
    STEATOHEPATITIS (NASH AND ASH), 2001, 121 : 197 - 202
  • [37] A novel non-alcoholic steatohepatitis animal model featured with insulin resistance, hepatic inflammation and fibrosis
    Zhao, Jingmin
    Zhou, Guangde
    Li, Meirong
    Li, Wenshu
    Lue, Jiyun
    Xiong, Lu
    Liang, Li
    Zhao, Yulai
    Xu, Dongping
    Yu, Jun
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 (11) : 1360 - 1371
  • [38] Hepatic Gap Junction Inhibition Limits Liver Injury and Inflammation in Non-alcoholic Steatohepatitis (NASH)
    Patel, Suraj J.
    Luther, Jay
    King, Kevin R.
    Bohr, Stefan
    Scichilone, John
    Garber, John
    Peng, Lee F.
    Chung, Raymond T.
    Yarmush, Martin L.
    HEPATOLOGY, 2013, 58 : 232A - 232A
  • [39] Targeting the Enterohepatic Bile Acid Signaling to Modulate Hepatic Autophagic Activity in Non-alcoholic steatohepatitis
    Wang, Yifeng
    Ding, Yifeng
    Li, Jibiao
    Chavan, Hemantkumar
    Matye, David
    Ni, Hongmin
    Krishnamurthy, Partha
    Ding, Wen-Xing
    Li, Tiangang
    FASEB JOURNAL, 2016, 30
  • [40] Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment
    Bugianesi, E
    Marzocchi, R
    Villanova, N
    Marchesini, G
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (06) : 1105 - 1116
12345